UTSW HIV Medicine (@utswim_hivmed) 's Twitter Profile
UTSW HIV Medicine

@utswim_hivmed

Providing comprehensive and rigorous fellowship training in both inpatient and outpatient HIV medical care.

ID: 1570164651576418305

linkhttps://bit.ly/3eSQaAh calendar_today14-09-2022 21:37:10

64 Tweet

66 Followers

61 Following

Susana Lazarte, MD (@idmdsusana) 's Twitter Profile Photo

Proudly announcing our most recent publication on the work we are doing on #KSHV in the Southern US Trying to understand why we see so much, specially among young men of color. ⁦UTSW Infectious Diseases & Geographic Medicine⁩ ⁦⁦Brad Cutrell, MD, FIDSA⁩⁦ academic.oup.com/jid/advance-ar…

UTSW HIV Medicine (@utswim_hivmed) 's Twitter Profile Photo

Interesting study just published from a collaboration including our very own Dr. Lazarte (Susana Lazarte, MD), Dr. Nijhawan, and Dr. Knights showing high regional incidence and prevalence of KSHV in young MSM. Has implications for who’s at risk for Kaposi’s Sarcoma!

Parkland Health (@parkland) 's Twitter Profile Photo

Parkland reminds you to #KnowYourStatus and get a no-cost #HIVscreening any Thursday in October in the Moody Outpatient Center Lobby, 5151 Maple Ave., Dallas, from 9 a.m. to 2 p.m. Register today here: parklandhealth.org/community-cale… #HIVAwareness #HIV

Parkland reminds you to #KnowYourStatus and get a no-cost #HIVscreening any Thursday in October in the Moody Outpatient Center Lobby, 5151 Maple Ave., Dallas, from 9 a.m. to 2 p.m. Register today here: parklandhealth.org/community-cale… 
#HIVAwareness #HIV
UTSW HIV Medicine (@utswim_hivmed) 's Twitter Profile Photo

Single dose liposomal amphotericin B may be non-inferior to standard 2-week induction in disseminated Histoplasmosis in PWH. Larger trials are likely needed, but fascinating results nonetheless

Open Forum Infectious Diseases (@ofidjournal) 's Twitter Profile Photo

Dolutegravir/lamivudine is non-inferior to continuing dolutegravir and non-dolutegravir based triple drug antiretroviral therapy in virologically suppressed people with HIV: DUALING prospective nationwide matched cohort study ✍️ Casper Rokx et al. 🔗 bit.ly/4cmJQtY

Dolutegravir/lamivudine is non-inferior to continuing dolutegravir and non-dolutegravir based triple drug antiretroviral therapy in virologically suppressed people with HIV: DUALING prospective nationwide matched cohort study

✍️ <a href="/Rokx1/">Casper Rokx</a> et al.
🔗 bit.ly/4cmJQtY
Infectious Diseases Education & Assessment (IDEA) (@uw_idea) 's Twitter Profile Photo

HCPs: DYK about our NEW curricula to help you learn how to assess, initiate, & monitor HIV PrEP? Earn up to 14 FREE CME/CNE/CE, access app, clinical guides, & multimedia. Quick reference lessons=no registration. bit.ly/4bfFEez

HCPs: DYK about our NEW curricula to help you learn  how to assess, initiate, &amp; monitor HIV PrEP? Earn up to 14 FREE CME/CNE/CE, access app, clinical guides, &amp; multimedia. Quick reference lessons=no registration.
bit.ly/4bfFEez
NEJM (@nejm) 's Twitter Profile Photo

Original Article: Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women (PURPOSE 1) nej.md/3zRElVj Editorial: The Real PURPOSE of PrEP — Effectiveness, Not Efficacy nej.md/3Yj3LW3 #AIDS2024 | IAS - the International AIDS Society

Original Article: Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women (PURPOSE 1) nej.md/3zRElVj 

Editorial: The Real PURPOSE of PrEP — Effectiveness, Not Efficacy nej.md/3Yj3LW3 

#AIDS2024 | <a href="/iasociety/">IAS - the International AIDS Society</a>
HIV.gov (@hivgov) 's Twitter Profile Photo

People with HIV are over-represented in current #mpox cases. If you have #HIV, you should follow the same recommendations as everyone else to protect yourself from mpox, including getting both doses of the JYNNEOS two-dose vaccine. Find an mpox vaccine: brnw.ch/21wLScA

People with HIV are over-represented in current #mpox cases.

If you have #HIV, you should follow the same recommendations as everyone else to protect yourself from mpox, including getting both doses of the JYNNEOS two-dose vaccine.

Find an mpox vaccine: brnw.ch/21wLScA
HIV Medicine Association (@hivma) 's Twitter Profile Photo

Southern HIV/AIDS Awareness Day is today! The theme Power to the People, reminds us to use our voices. 7 Southern states still haven’t expanded Medicaid, leaving thousands without essential HIV care. Closing the #Medicaid gap is crucial to #EndHIVEpidemic. Learn more in HIVMA's

Southern HIV/AIDS Awareness Day is today! The theme Power to the People, reminds us to use our voices. 7 Southern states still haven’t expanded Medicaid, leaving thousands without essential HIV care. Closing the #Medicaid gap is crucial to #EndHIVEpidemic. Learn more in HIVMA's
Clinical Infectious Diseases (@cidjournal) 's Twitter Profile Photo

The risk of non-AIDS defining events is lower in ART-naive HIV controllers than normal progressors on suppressive ART ✅ Just Accepted bit.ly/4cLdice

UTSW HIV Medicine (@utswim_hivmed) 's Twitter Profile Photo

Congratulations Josh Estrada Joshua Estrada for being named Parkland Health ‘s PA of the Year! We are fortunate to work such dedicated APPs in ACCESS clinic, providing exceptional care to PLWH

Congratulations Josh Estrada <a href="/JoshuaThePA/">Joshua Estrada</a> for being named <a href="/Parkland/">Parkland Health</a> ‘s PA of the Year!  We are fortunate to work such dedicated APPs in ACCESS clinic, providing exceptional care to PLWH
Clinical Infectious Diseases (@cidjournal) 's Twitter Profile Photo

Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America ✅ Just Accepted 🔗 bit.ly/3BHzbfu

Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America

✅ Just Accepted
🔗 bit.ly/3BHzbfu
HIV.gov (@hivgov) 's Twitter Profile Photo

Mpox - The #NIAID-sponsored STOMP study found the antiviral drug tecovirimat was safe but did not improve #mpox resolution or pain among adults in countries affected by clade II mpox. Learn more: go.nih.gov/TKPVNhV NIAID News

Mpox - The #NIAID-sponsored STOMP study found the antiviral drug tecovirimat was safe but did not improve #mpox resolution or pain among adults in countries affected by clade II mpox. Learn more: go.nih.gov/TKPVNhV
<a href="/NIAIDNews/">NIAID News</a>